Patents by Inventor Arnaud Beduneau

Arnaud Beduneau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PARTICULATE STRUCTURES MADE FROM GOLD NANOPARTICLES, METHODS FOR PREPARING SAME AND USES THEREOF FOR TREATING SOLID TUMOURS
    Publication number: 20220257801
    Abstract: A particulate structure that includes a/ a biodegradable polymer particle, b/ gold nanoparticles covered on their surface with macrocyclic chelators complexing at least one ion of interest and/or a radionuclide for medical imaging, c/ a polycation having a positive charge over a pH range from 5 to 11, the gold nanoparticles b/ being encapsulated in the polymer particle a/ and/or adsorbed at the surface of the polymer particle a/. Also, a method for preparing the particulate structures. Further, the use of the particulate structures for radiotherapy or chemotherapy in the context of cancer treatment.
    Type: Application
    Filed: July 23, 2020
    Publication date: August 18, 2022
    Applicant: UNIVERSITE DE FRANCHE COMTE
    Inventors: Gautier LAURENT, Arnaud BEDUNEAU, Stéphane ROUX
  • Compositions and methods for drug delivery
    Patent number: 9364443
    Abstract: The present disclosure is directed to surface-modified particles and to methods of making and using the same. The surface-modified particles comprise a particle core and a coating associated with the particle core, wherein the particle core comprises an active agent, the coating comprises an opsonin, and the surface-modified particle has an average size from about 1 nm to about 2,000 nm.
    Type: Grant
    Filed: March 5, 2009
    Date of Patent: June 14, 2016
    Assignees: BAXTER INTERNATIONAL, INC., BAXTER HEALTHCARE SA, BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
    Inventors: Arnaud Beduneau, Howard Gendelman, Barrett Rabinow, Jane Werling
  • CELL CULTURE METHOD AND SYSTEM FOR ESTABLISHING AN IN VITRO MODEL OF THE INTESTINAL BARRIER
    Publication number: 20130302888
    Abstract: Cell culture process includes seeding a suitable culture medium with enterocytes and then, after a delay, seeding the medium containing the enterocytes that have begun to proliferate, with goblet cells.
    Type: Application
    Filed: February 17, 2012
    Publication date: November 14, 2013
    Applicant: GATTEFOSSE SAS
    Inventors: Frederic Demarne, Vincent Jannin, Alf Lamprecht, Yann Pellequer, Arnaud Beduneau
  • Compositions and Methods for Drug Delivery
    Publication number: 20090274765
    Abstract: The present disclosure is directed to surface-modified particles and to methods of making and using the same. The surface-modified particles comprise a particle core and a coating associated with the particle core, wherein the particle core comprises an active agent, the coating comprises an opsonin, and the surface-modified particle has an average size from about 1 nm to about 2,000 nm.
    Type: Application
    Filed: March 5, 2009
    Publication date: November 5, 2009
    Applicants: BAXTER INTERNATIONAL INC., BAXTER HEALTHCARE S.A., BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
    Inventors: Arnaud Beduneau, Howard Gendelman, Barrett Rabinow, Jane Werling